Seed Round - Antegenes

Seed Round - Antegenes

Investment Firm

Overview

Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.

Announced Date

Aug 02, 2022

Funding Type

Seed

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

1

Investor Name
Participant InvestorTimo Rein

Round Details and Background

Antegenes raised $1625058 on 2022-08-02 in Seed Round

Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 10, 2021
Pre Seed Round - Antegenes
-574.3K
Feb 01, 2018
Angel Round - Antegenes
-312.8K
Aug 02, 2022
Seed Round - Antegenes
4-1.6M
Aug 02, 2022
Grant - Antegenes
2-711.0K

Recent Activity

There is no recent news or activity for this profile.